| Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure M Packer, JJV McMurray, AS Desai, J Gong, MP Lefkowitz, AR Rizkala, ... Circulation 131 (1), 54-61, 2015 | 803 | 2015 |
| Polypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards. The REPOSI study A Nobili, G Licata, F Salerno, L Pasina, M Tettamanti, C Franchi, ... European journal of clinical pharmacology 67, 507-519, 2011 | 407 | 2011 |
| Practice guidelines for the therapy of essential thrombocythemia. A statement from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the … T Barbui, G Barosi, A Grossi, L Gugliotta, LN Liberato, M Marchetti, ... haematologica 89 (2), 215-232, 2004 | 396 | 2004 |
| Risk related to pre–diabetes mellitus and diabetes mellitus in heart failure with reduced ejection fraction: insights from prospective comparison of ARNI With ACEI to determine … SL Kristensen, D Preiss, PS Jhund, I Squire, JS Cardoso, B Merkely, ... Circulation: Heart Failure 9 (1), e002560, 2016 | 383 | 2016 |
| Outcomes of patients hospitalized with community-acquired, health care–associated, and hospital-acquired pneumonia M Venditti, M Falcone, S Corrao, G Licata, P Serra, ... Annals of internal medicine 150 (1), 19-26, 2009 | 363 | 2009 |
| The Italian Consensus Conference on diagnostic criteria for myelofibrosis with myeloid metaplasia G Barosi, A Ambrosetti, C Finelli, A Grossi, P Leoni, NL Liberato, MC Petti, ... British journal of haematology 104 (4), 730-737, 1999 | 251 | 1999 |
| Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. Results of a phase I/II clinical trial [see comments] M Cazzola, L Ponchio, Y Beguin, V Rosti, G Bergamaschi, NL Liberato, ... | 187 | 1992 |
| Multimorbidity and polypharmacy in the elderly: lessons from REPOSI PM Mannucci, A Nobili, RePoSi Investigators Internal and emergency medicine 9, 723-734, 2014 | 176 | 2014 |
| Association between clusters of diseases and polypharmacy in hospitalized elderly patients: results from the REPOSI study A Nobili, A Marengoni, M Tettamanti, F Salerno, L Pasina, C Franchi, ... European journal of internal medicine 22 (6), 597-602, 2011 | 176 | 2011 |
| Cost effectiveness of adjuvant trastuzumab in human epidermal growth factor receptor 2–positive breast cancer NL Liberato, M Marchetti, G Barosi Journal of Clinical Oncology 25 (6), 625-633, 2007 | 165 | 2007 |
| Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial F Perrone, MC Piccirillo, PA Ascierto, C Salvarani, R Parrella, AM Marata, ... Journal of translational medicine 18 (1), 405, 2020 | 153 | 2020 |
| Prevalence and appropriateness of drug prescriptions for peptic ulcer and gastro-esophageal reflux disease in a cohort of hospitalized elderly L Pasina, A Nobili, M Tettamanti, F Salerno, S Corrao, A Marengoni, ... European journal of internal medicine 22 (2), 205-210, 2011 | 132 | 2011 |
| A prognostic classification of myelofibrosis with myeloid metaplasia G Barosi, C Berzuini, LN Liberato, A Costa, G Polino, E Ascari British journal of haematology 70 (4), 397-401, 1988 | 131 | 1988 |
| Risk factors for hospital readmission of elderly patients C Franchi, A Nobili, D Mari, M Tettamanti, CD Djade, L Pasina, F Salerno, ... European journal of internal medicine 24 (1), 45-51, 2013 | 120 | 2013 |
| Cost-effectiveness of recombinant human erythropoietin in the prevention of chemotherapy-induced anaemia G Barosi, M Marchetti, NL Liberato British journal of cancer 78 (6), 781-787, 1998 | 108 | 1998 |
| Gender-differences in disease distribution and outcome in hospitalized elderly: data from the REPOSI study S Corrao, P Santalucia, C Argano, CD Djade, E Barone, M Tettamanti, ... European journal of internal medicine 25 (7), 617-623, 2014 | 104 | 2014 |
| Prevalence of potentially inappropriate medications and risk of adverse clinical outcome in a cohort of hospitalized elderly patients: results from the REPOSI Study L Pasina, CD Djade, M Tettamanti, C Franchi, F Salerno, S Corrao, ... Journal of clinical pharmacy and therapeutics 39 (5), 511-515, 2014 | 97 | 2014 |
| Splenectomy for patients with myelofibrosis with myeloid metaplasia: pretreatment variables and outcome prediction. G Barosi, A Ambrosetti, A Buratti, C Finelli, NL Liberato, S Quaglini, ... Leukemia 7 (2), 200-206, 1993 | 97 | 1993 |
| Mortality rate and risk factors for gastrointestinal bleeding in elderly patients MV Lenti, L Pasina, S Cococcia, L Cortesi, E Miceli, CC Dominioni, ... European Journal of Internal Medicine 61, 54-61, 2019 | 95 | 2019 |
| Drug–drug interactions in a cohort of hospitalized elderly patients L Pasina, CD Djade, A Nobili, M Tettamanti, C Franchi, F Salerno, ... pharmacoepidemiology and drug safety 22 (10), 1054-1060, 2013 | 88 | 2013 |
